Home > Healthcare > Biotechnology > Biotechnology R&D > Transfection Technologies Market

Transfection Technologies Market Share

Report ID: GMI9113
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Transfection Technologies Market Share

The transfection technologies industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Transfection Technologies Market Companies

Some of the eminent market participants operating in the transfection technologies industry include:

Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd
Lonza
MaxCyte, Inc.
QIAGEN N.V.
Revvity, Inc.
Sartorius AG
Thermo Fisher Scientific, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Transfection technologies market size was worth USD 1.2 billion in 2023 and will grow at an 8.2% CAGR between 2024 and 2032, fueled by integral role in genetic testing, biotechnology, and pharmaceutical development

The kits and reagents segment recorded USD 828.5 million in 2023 led by the surge in product launches by major players

North America transfection technologies industry size will record USD 1.1 billion by 2032, owing to substantial investments in biotechnology and pharmaceutical research

Some of the leading transfection technologies industry players include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Lonza, MaxCyte, Inc., QIAGEN N.V., and Revvity, Inc. among others.